My expertise is in vaccines.
It is extremely difficult to make biologic products. If you're developing an infant vaccine, for example, Pediacel, if you have a quality issue, that whole vat will have to be removed, and that is an 18-month delay. We have to replenish the supply. It's very challenging. We do everything we can to maintain the integrity of our manufacturing processes, and that's why our levels of quality are so high. Health Canada inspects us regularly.
We do our best. We're trying not to have breakdowns in supply, but it is part of the manufacturing process. We work with Health Canada. We have drug shortage notification protocols on the Health Canada website. Whenever we are in a situation where we start to run short, we will always post them. If it's a situation where a patient is running into a drug shortage, we always ask them to call their health care professional to look for alternatives.